Plasma calprotectin predicts mortality in patients with ST segment elevation myocardial infarction treated with primary percutaneous coronary intervention

Journal of Interventional Cardiology

Volumn 23, Issue 2, 2010, Pages 123-129

  Jensen, Louise J N ^a   Pedersen, Sune ^b   Bjerre, Mette ^a   Mogelvang, Rasmus ^b,d   Jensen, Jan Skov ^b,c   Flyvbjerg, Allan ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d HOLBÆK HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

CALGRANULIN; CREATINE KINASE MB;

AGED; ARTERY OCCLUSION; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL FEATURE; CONTROLLED STUDY; CREATINE KINASE BLOOD LEVEL; FEMALE; HUMAN; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; SURVIVAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BIOLOGICAL MARKERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK; TREATMENT OUTCOME;

EID: 77950558969     PISSN: 08964327     EISSN: 15408183     Source Type: Journal    
DOI: 10.1111/j.1540-8183.2010.00532.x     Document Type: Article

References (21)

1. Andersen HR, Nielsen TT, Rasmussen K, et al. A comparison of coronary angioplasty with fibrinolytic therapy in acute myocardial infarction. N Engl J Med 2003 349 : 733 742. (Pubitemid 37010777)
2. Boden WE, Eagle K, Granger CB. Reperfusion strategies in acute ST-segment elevation myocardial infarction: A comprehensive review of contemporary management options. J Am Coll Cardiol 2007 50 : 917 929. (Pubitemid 47313604)
3. Bolli R, Becker L, Gross G, et al. Myocardial protection at a crossroads: The need for translation into clinical therapy. Circ Res 2004 95 : 125 134. (Pubitemid 38988678)
4. Dirksen MT, Laarman GJ, Simoons ML, et al. Reperfusion injury in humans: A review of clinical trials on reperfusion injury inhibitory strategies. Cardiovasc Res 2007 74 : 343 355.
5. Yellon DM, Hausenloy DJ. Myocardial reperfusion injury. N Engl J Med 2007 357 : 1121 1135.
6. Haidari M, Javadi E Sadeghi B, et al. Evaluation of C-reactive protein, a sensitve marker of inflammation, as a risk factor for stable coronar artery disease. Clin Biochem 2001 34 : 309 315. (Pubitemid 32607574)
7. Rifai N, Joubran R, Yu H, et al. Inflammatory markers in men with angiographically documented coronary heart disease. Clin Chem 1999 45 : 1967 1973. (Pubitemid 29522005)
8. Lindahl B, Toss H, Siegbahn A, et al. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Eng J Med 2000 343 : 1139 1147. (Pubitemid 32183591)
9. Koenig W, Sund M, Fröhlich M, et al. C-reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg cohort study, 1984 to 1992. Circulation 1999 99 : 237 242.
10. Mendall MA, Patel P, Ballam L, et al. C-reactive protein and its relation to cardiovascular risk factors: A population based cross sectional study. BMJ 1996 312 : 1061 1065.
11. Apple FS, Wu AH, Mair J, et al. Future biomarkers for detection of ischemia and risk stratification in acute coronary syndrome. Clin Chem 2005 51 : 810 824.
12. Hessian PA, Edgeworth J, Hogg N. MRP-8 and MRP-14, two abundant Ca(2+)-binding proteins of neutrophils and monocytes. J Leukoc Biol 1993 53 : 197 204.
13. Teigelkamp S, Bhardwaj RS, Roth J, et al. Calcium-dependent complex assembly of the myeloic differentiation proteins MRP-8 and MRP-14. J Biol Chem 1991 266 : 13462 13467.
14. Ho GT, Lee HM, Brydon G, et al. Fecal calprotectin predicts the clinical course of acute ulcerative colitis. Am J Gastroenterol 2009 104 : 673 678.
15. Healy AM, Pickard MD, Pradhan AD, et al. Platelet expression profiling and clinical validation of myeloid-related protein-14 as a novel determinant of cardiovascular events. Circulation 2006 113 : 2278 2284.
16. Altwegg LA, Neidhart M, Hersberger M, et al. Myeloid-related protein 814 complex is released by monocytes and granulocytes at the site of coronary occlusion: A novel, early, and sensitive marker of acute coronary syndromes. Eur Heart J 2007 28 : 941 948.
17. Miyamoto S, Ueda M, Ikemoto M, et al. Increased serum levels and expression of S100A8A9 complex in infiltrated neutrophils in atherosclerotic plaque of unstable angina. Heart 2008 94 : 1002 1007.
18. Morrow DA, Wang Y, Croce K, et al. Myeloid-related protein 814 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin evaluation and infection therapy: Thrombolysis in Myocardial Infarction Trial. Am Heart J 2008 155 : 49 55.
19. Viemann D, Strey A, Janning A, et al. Myeloid-related proteins 8 and 14 induce specific inflammatory response in human microvascular endothelial cells. Blood 2005 105 : 2955 2962.
20. Ehlermann P, Eggers K, Bierhaus A, et al. Increased proinflammatory endothelial response to S100A8A9 after preactivation through advanced glycation end products. Cardiovasc Diabetol 2006 5 : 6.
21. Ghavami S, Rashedi I, Dattilo BM, et al. S100A8A9 at low concentration promotes tumor cell growth via RAGE and MAP kinase-dependent pathway. J Leukoc Biol 2008 83 : 1484 1492.